Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02615652
Other study ID # University of Konstanz
Secondary ID
Status Completed
Phase N/A
First received November 22, 2015
Last updated May 10, 2017
Start date December 2015
Est. completion date July 2016

Study information

Verified date May 2017
Source University of Konstanz
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Researchers of the three collaborating universities implement a pilot observational study in "Gilgel Gibe Field Research Center", a health and demographic surveillance system run by the Jimma University, Ethiopia. In this setting, the investigators plan to study risk factors in young men for the development of common mental disorders and psychotic symptoms and the stability of distinct symptoms of mental disorders in the community. The investigators will explore in particular the impact of lifestyle on mental health in young men, including the traditional habit of chewing khat leaves, which contain amphetamine-like cathinone. Furthermore, the investigators want to demonstrate the reliability and validity of assessments performed by trained local interviewers.


Recruitment information / eligibility

Status Completed
Enrollment 865
Est. completion date July 2016
Est. primary completion date January 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- Male, Age 18 - 30, permanent residents in Gilgel Gibe

Exclusion Criteria:

- Prior existing severe mental health problems

Study Design


Intervention

Other:
no intervention
no intervention, observational study

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
University of Konstanz Jimma University, Ludwig-Maximilians - University of Munich

Outcome

Type Measure Description Time frame Safety issue
Primary psychotic symptoms presence of self-reported psychotic symptoms during the month before interview through study completion, within 2 months
Primary symptoms of Common Mental Disorders presence of self-reported CMD symptoms during the month before interview through study completion, within 2 months
Secondary amount of khat use self-reported amount of khat standard units consumed last week through study completion, within 2 months
Secondary amount of alcohol use self-reported amount of alcohol standard units consumed last week through study completion, within 2 months
See also
  Status Clinical Trial Phase
Completed NCT04038788 - Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia N/A
Completed NCT03701100 - The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia N/A